DLHC

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

Wall Street analysts forecast DLHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DLHC is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

DLH Holdings Corp revenue for the last quarter amounts to 81.16M USD, decreased -15.80 % YoY.

DLH Holdings Corp. EPS for the last quarter amounts to -0.06 USD, decreased -137.50 % YoY.

DLH Holdings Corp (DLHC) has 2300 emplpoyees as of December 16 2025.

Today DLHC has the market capitalization of 80.73M USD.